Vanguard Group Inc Aim Immuno Tech Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,988,704 shares of AIM stock, worth $457,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,988,704
Previous 1,988,704
-0.0%
Holding current value
$457,401
Previous $735,000
27.07%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AIM
# of Institutions
36Shares Held
9.01MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.33MShares$995,9000.02% of portfolio
-
Black Rock Inc. New York, NY698KShares$160,6010.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$106,7230.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il458KShares$105,2860.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny243KShares$55,9370.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $11.1M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...